ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.
MiRNAs are endogenous ~22 nt RNAs which play critical regulatory roles in a wide range of biological and pathological processes, which can act as oncogenes or tumor suppressor genes depending on their target genes. We have recently shown that ANXA1 inhibits the expression of miRNAs including miR196a. Here, we show that miR196a was highly expressed in ER+ MCF-7 breast cancer cells when compared to normal mammary gland cells, with expression levels negatively correlating to ANXA1. ANXA1 inhibits the biogenesis of oncogenic miR-196a by suppressing primary-miR196a indirectly through the stimulation of c-myc and NFkB expression and activity in breast cancer cells. In a negative feedback loop, miR-196a directly inhibits ANXA1 and enhances breast cancer cell proliferation in vitro. Finally, miR196a promotes breast tumor growth in vivo. This study reports a novel regulatory circuit between ANXA1, NF-kB, c-myc and miR-196a which regulates breast cancer cell proliferation and tumor growth.
Department of Physiology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore (NUS), Singapore.
Yi
Y
Yuan
Department of Physiology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore (NUS), Singapore.
Durkeshwari
D
Anbalagan
Department of Physiology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore (NUS), Singapore.
Lay Hoon
LH
Lee
Department of Physiology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore (NUS), Singapore.
Ramar Perumal
RP
Samy
Department of Pharmacology, Yong Loo Lin School of Medicine, NUHS, National University of Singapore, Singapore.
Muthu K
MK
Shanmugam
Department of Pharmacology, Yong Loo Lin School of Medicine, NUHS, National University of Singapore, Singapore.|Cancer Science Institute of Singapore, National University of Singapore, Singapore.|School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia.|National University Cancer Institute, NUHS, Singapore.|Department of Biological Sciences, University of North Texas, Denton, Texas, United States of America.
Alan Prem
AP
Kumar
Department of Pharmacology, Yong Loo Lin School of Medicine, NUHS, National University of Singapore, Singapore.
Gautam
G
Sethi
Department of Pharmacology, Yong Loo Lin School of Medicine, NUHS, National University of Singapore, Singapore.|Cancer Science Institute of Singapore, National University of Singapore, Singapore.
Peter E
PE
Lobie
Department of Physiology, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore (NUS), Singapore.|NUS Immunology Program, Life Sciences Institute, NUS, Singapore.
Lina H K
LH
Lim
D000818:Animals; D017305:Annexin A1 / Q000235:genetics* / Q000378:metabolism; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000235:genetics*; D025461:Feedback, Physiological; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D061986:MCF-7 Cells; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D035683:MicroRNAs / Q000235:genetics*; D016328:NF-kappa B / Q000235:genetics* / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics* / Q000378:metabolism; D034622:RNA Interference; D014183:Transplantation, Heterologous; D047368:Tumor Burden / Q000235:genetics
D017305:Annexin A1; C542543:MIRN196 microRNA, human; C489427:MYC protein, human; D035683:MicroRNAs; D016328:NF-kappa B; D016271:Proto-Oncogene Proteins c-myc
Immune response; Immunity; Immunology and Microbiology Section; annexin 1; breast cancer; c-myc; microRNAs; pri-miR-196a